Los Angeles Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.4K | Hold |
48,172
| – | – | ﹤0.01% | 1308 |
|
|
2025
Q1 | $69.4K | Buy |
+48,172
| New | +$69.4K | ﹤0.01% | 1070 |
|
|
2021
Q2 | – | Sell |
-18,005
| Closed | -$505K | – | 1576 |
|
|
2021
Q1 | $505K | Sell |
18,005
-13,062
| -42% | -$366K | ﹤0.01% | 1213 |
|
|
2020
Q4 | $808K | Sell |
31,067
-25
| -0.1% | -$650 | ﹤0.01% | 1026 |
|
|
2020
Q3 | $1.16M | Hold |
31,092
| – | – | 0.01% | 768 |
|
|
2020
Q2 | $1.6M | Sell |
31,092
-225
| -0.7% | -$11.5K | 0.01% | 684 |
|
|
2020
Q1 | $987K | Sell |
31,317
-9,068
| -22% | -$286K | 0.01% | 712 |
|
|
2019
Q4 | $2.41M | Sell |
40,385
-6,305
| -14% | -$376K | 0.01% | 596 |
|
|
2019
Q3 | $1.71M | Buy |
46,690
+19,170
| +70% | +$703K | 0.01% | 671 |
|
|
2019
Q2 | $1.28M | Buy |
+27,520
| New | +$1.28M | 0.01% | 763 |
|
|
2018
Q2 | – | Sell |
-3,160
| Closed | -$229K | – | 1448 |
|
|
2018
Q1 | $229K | Buy |
+3,160
| New | +$229K | ﹤0.01% | 1236 |
|